Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia
Abstract
Animal studies and cell culture experiments demonstrated that posttranscriptional editing of the transcript of the GluR-2 gene, resulting in substitution of an arginine for glutamine in the second transmembrane region (TM II) of the expressed protein, is associated with a reduction in Ca2+ permeability of the receptor channel. Thus, disturbances in GluR-2 RNA editing with alteration of intracellular Ca2+ homeostasis could lead to neuronal dysfunction and even neuronal degeneration. The present study determined the proportions of edited and unedited GluR-2 RNA in the prefrontal cortex of brains from patients with Alzheimer's disease, in the striatum of brains from patients with Huntington's disease, and in the same areas of brains from age-matched schizophrenics and controls, by using reverse transcriptase-polymerase chain reaction, restriction endonuclease digestion, gel electrophoresis and scintillation radiometry. In the prefrontal cortex of controls, 99.9% were edited; in the prefrontal cortex both of schizophrenics and of Alzheimer's patients approximately 1.0% of all GluR-2 RNA molecules were unedited and 99% were edited. In the striatum of controls and of schizophrenics, approximately 0.5% of GluR-2 RNA molecules were unedited and 99.5% were edited; in the striatum of Huntington's patients nearly 5.0% of GluR-2 RNA was unedited. In the prefrontal white matter of controls, approximately 7.0% of GluR-2 RNA was unedited. In the normal human prefrontal cortex and striatum,…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In BM36, altered A-to-I editing sites include GRIA2 (R/G and Q/R), GRIK2 (Q/R), and NOVA1 (S/G).
“For example, in BM36, we identified well characterized A-to-I editing sites of GRIA2 (R/G and Q/R) (55, 75, 76) and GRIK2 (Q/R) (29, 77), as well as previously reported editing sites in NOVA1 (S/G) (29, 56) (Fig. 5D).”
From Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains (2025) · cites this paper as [75]
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · see citing works
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · see citing works
Chomczyński, P. (1993) · PubMed · Cited by 2,788 · see citing works
Neuropathological Classification of Huntingtonʼs Disease
Vonsattel, J., Myers, R. H., STEVENS, T. J., Ferrante, R. J., Bird, E. D., & Richardson, E. P. (1985) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,598 · see citing works
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
Sommer, B., Köhler, M., Sprengel, R., & Seeburg, P. H. (1991) · Cell · doi:10.1016/0092-8674(91)90568-j · Cited by 1,517 · see citing works
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.2166337 · Cited by 1,479 · see citing works
Burnashev, N., Monyer, H., Seeburg, P. H., & Sakmann, B. (1992) · Neuron · doi:10.1016/0896-6273(92)90120-3 · Cited by 1,087 · see citing works
Cloning by functional expression of a member of the glutamate receptor family
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W., & Heinemann, S. F. (1989) · Nature · doi:10.1038/342643a0 · Cited by 1,016 · see citing works
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002 · see citing works
Self-citationMolecular Cloning and Functional Expression of Glutamate Receptor Subunit Genes
Boulter, J., Hollmann, M., O'Shea-Greenfield, A., Hartley, M., Deneris, E. S., Maron, C., & Heinemann, S. F. (1990) · Science · doi:10.1126/science.2168579 · Cited by 939 · see citing works
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921 · see citing works
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 894 · see citing works
Structural Determinants of Ion Flow Through Recombinant Glutamate Receptor Channels
Verdoorn, T. A., Burnashev, N., Monyer, H., Seeburg, P. H., & Sakmann, B. J. (1991) · Science · doi:10.1126/science.1710829 · Cited by 815 · see citing works
Control of Kinetic Properties of AMPA Receptor Channels by Nuclear RNA Editing
Lomeli, H., Mosbacher, J., Melcher, T., Höger, T., Geiger, J. R. P., Kuner, T., Monyer, H., Higuchi, M., Bach, A., & Seeburg, P. H. (1994) · Science · doi:10.1126/science.7992055 · Cited by 746 · see citing works
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150007001 · Cited by 679 · see citing works
Self-citationHiguchi, M., Single, F. N., Köhler, M. G., Sommer, B., Sprengel, R., & SEEBURG, P. H. (1993) · Cell · doi:10.1016/0092-8674(93)90622-w · Cited by 662 · see citing works
Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
Beal, M. F., Hyman, B. T., & Koroshetz, W. J. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90117-5 · Cited by 574 · see citing works
AMPA glutamate receptor subunits are differentially distributed in rat brain
Martin, L. J., Blackstone, C. D., Levey, A. I., Huganir, R. L., & Price, D. L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90199-p · Cited by 569 · see citing works
Kostović, I., & RAKIC, P. T. (1980) · Journal of Neurocytology · doi:10.1007/bf01205159 · Cited by 499 · see citing works
Köhler, M. G., Burnashev, N., Sakmann, B. J., & Seeburg, P. H. (1993) · Neuron · doi:10.1016/0896-6273(93)90336-p · Cited by 458 · see citing works
Hendry, S., Jones, E. G., & Emson, P. C. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-10-02497.1984 · Cited by 415 · see citing works
Self-citationMaking the diagnosis of Alzheimer's disease. A primer for practicing pathologists.
Mirra, S. S., Hart, M. N., & Terry, R. D. (1993) · PubMed · Cited by 412 · see citing works
Randall, R. D., & Thayer, S. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01882.1992 · Cited by 408 · see citing works
Excitotoxic Amino Acids and Neuropsychiatric Disorders
Olney, J. W. (1990) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.000403 · Cited by 407 · see citing works
Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations
Michaels, R. L., & Rothman, S. M. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00283.1990 · Cited by 342 · see citing works
Frontostriatal Disorder of Cerebral Metabolism in Never-Medicated Schizophrenics
Buchsbaum, M. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120023005 · Cited by 324 · see citing works
Patneau, D. K., Wright, P. W., Winters, C. A., Mayer, M. L., & Gallo, V. (1994) · Neuron · doi:10.1016/0896-6273(94)90277-1 · Cited by 314 · see citing works
Ca2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6.
Egebjerg, J., & Heinemann, S. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.755 · Cited by 300 · see citing works
Dickson, D. W., Davies, P., Bevona, C., van Hoeven, K. H., Factor, S. M., Grober, E. H., Aronson, M. K., & Crystal, H. (1994) · Acta Neuropathologica · doi:10.1007/bf00293396 · Cited by 293 · see citing works
The Calcium Channel Blocker Nifedipine Attenuates Slow Excitatory Amino Acid Neurotoxicity
Weiss, J. H., Hartley, D. M., Koh, J., & Choi, D. W. (1990) · Science · doi:10.1126/science.2157282 · Cited by 273 · see citing works
Tymianski, M., Wallace, M. C., Spigelman, I., Uno, M., Carlen, P. L., Tator, C. H., & Charlton, M. P. (1993) · Neuron · doi:10.1016/0896-6273(93)90180-y · Cited by 219 · see citing works
Excitatory Amino Acid‐Mediated Cytotoxicity and Calcium Homeostasis in Cultured Neurons
Frandsen, A., & Schousboe, A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03278.x · Cited by 215 · see citing works
Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study
Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J., & Muenz, L. R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90152-x · Cited by 183 · see citing works
Selective RNA editing and subunit assembly of native glutamate receptors
Puchalski, R. B., Louis, J., Brose, N., Traynelis, S. F., Egebjerg, J., Kukekov, V. G., Wenthold, R. J., Rogers, S. W., Lin, F., Moran, T. M., et al. (1994) · Neuron · doi:10.1016/0896-6273(94)90464-2 · Cited by 156 · see citing works
Is there gliosis in schizophrenia? Investigation of the temporal lobe
Roberts, G. W., Colter, N., Lofthouse, R., Johnstone, E. C., & Crow, T. J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90104-1 · Cited by 154 · see citing works
Gliosis in schizophrenia: A survey
Roberts, G. W., Colter, N., Lofthouse, R., Bogerts, B., Zech, M.-P., & Crow, T. J. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90285-4 · Cited by 150 · see citing works
Wyllie, D. J. A., Mathie, A. A., Symonds, C. J., & Cull-Candy, S. G. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018383 · Cited by 148 · see citing works
Рапопорт, С. И. (1991) · PubMed · Cited by 145 · see citing works
Bernard, A., & Khrestchatisky, M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62052057.x · Cited by 125 · see citing works
Jensen, A., & Chiu, S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01674.1991 · Cited by 123 · see citing works
Pharmacological characterization of the glutamate receptor in cultured astrocytes
Backus, K. H., Kettenmann, H., & Schachner, M. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220307 · Cited by 121 · see citing works
Murray, K. D., Gall, C. M., Jones, E. G., & Isackson, P. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90202-x · Cited by 110 · see citing works
Self-citationSimonian, N. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00010 · Cited by 108 · see citing works
Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity
Lei, S. Z., Zhang, D., Abele, A. E., & Lipton, S. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)90183-a · Cited by 105 · see citing works
RNA Editing of the Glutamate Receptor Subunits GluR2 and GluR6 in Human Brain Tissue
Paschen, W., Hedreen, J. C., & Ross, C. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051596.x · Cited by 75 · see citing works
Albin, R. L., Qin, Y., Young, A. B., Penney, J. B., & Chesselet, M. (1991) · Annals of Neurology · doi:10.1002/ana.410300406 · Cited by 66 · see citing works
Ca(2+)-dependent processes as mediators of neurotoxicity.
Verity, M. A. (1992) · PubMed · Cited by 62 · see citing works
Harrison, P. J., BARTON, A. J. L., McDonald, B., & Pearson, R. C. A. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90058-6 · Cited by 56 · see citing works
Hippocampal sclerosis: a common pathological feature of dementia in very old humans
Jellinger, K. A. (1994) · Acta Neuropathologica · doi:10.1007/bf00296500 · Cited by 50 · see citing works
AMPA/kainate receptor gene expression in normal and Alzheimer's disease hippocampus.
Pellegrini-Giampietro, D., Bennett, M. V. L., & Zukin, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90058-2 · Cited by 46 · see citing works
Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor
Caner, H., Collins, J. L., Harris, S. M., Kassell, N. F., & Lee, K. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)91531-v · Cited by 42 · see citing works
Excitatory amino acids and neurotoxicity.
Bruno, V., Scapagnini, U., & Canonico, P. L. (1994) · PubMed · Cited by 29 · see citing works
AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus
Eastwood, S. L., Burnet, P. W. J., Beckwith, J., Kerwin, R. W., & Harrison, P. J. (1994) · Neuroreport · doi:10.1097/00001756-199406270-00007 · Cited by 26 · see citing works
Weiss, J. H., & Choi, D. W. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032522 · Cited by 22 · see citing works
Schousboe, A., Frandsen, A., & Krogsgaard‐Larsen, P. (1992) · Cell Biology and Toxicology · doi:10.1007/bf00130515 · Cited by 21 · see citing works
Effects of domoate, glutamate and glucose deprivation on calcium uptake by rat brain tissue in vitro
NIJJAR, M. S. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90357-3 · Cited by 18 · see citing works
Hamill, R., Markesbery, W., McDaniel, K., & Coleman, P. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90037-c · Cited by 7 · see citing works
Flagged first, then by citations
2 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882 · see citing works
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · see citing works
RNA editing and death of motor neurons
Kawahara, Y., Ito, K., Sun, H. J., Aizawa, H., Kanazawa, I., & Kwak, S. (2004) · Nature · doi:10.1038/427801a · Cited by 536 · see citing works
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381 · see citing works
Rodent models of prefrontal cortical function
Brown, V. J., & Bowman, E. M. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02164-1 · Cited by 321 · see citing works
Apoptotic mechanisms and the synaptic pathology of schizophrenia
Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.014 · Cited by 289 · see citing works
Generation of neuronal variability and complexity
Muotri, A. R., & Gage, F. H. (2006) · Nature · doi:10.1038/nature04959 · Cited by 271 · see citing works
The many roles of an RNA editor
Keegan, L. P., Gallo, A., & O’Connell, M. A. (2001) · Nature Reviews Genetics · doi:10.1038/35098584 · Cited by 253 · see citing works
Tanaka, H., Grooms, S. Y., Bennett, M. V. L., & Zukin, R. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02951-6 · Cited by 244 · see citing works
Structural brain imaging in schizophrenia: a selective review
Pearlson, G. D., & Marsh, L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00071-2 · Cited by 219 · see citing works
Apoptotic mechanisms in the pathophysiology of schizophrenia
Jarskog, L. F., Glantz, L. A., Gilmore, J. H., & Lieberman, J. A. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.010 · Cited by 214 · see citing works
Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis
Kwak, S., & Kawahara, Y. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0599-z · Cited by 215 · see citing works
The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain
Wright, A. L., & Vissel, B. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00034 · Cited by 214 · see citing works
Palmer, C. L., Cotton, L., & Henley, J. M. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.7 · Cited by 211 · see citing works
Huntingtin aggregates may not predict neuronal death in Huntington's disease
Kuemmerle, S., Gutekunst, C., Klein, A., Li, X., Li, S.-H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6 · Cited by 387 · see citing works
Cicchetti, F., Prensa, L., Wu, Y., & Parent, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00039-4 · Cited by 192 · see citing works
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons
Hideyama, T., Yamashita, T., Aizawa, H., Tsuji, S., Kakita, A., Takahashi, H., & Kwak, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.033 · Cited by 189 · see citing works
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188 · see citing works
Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders
Guo, C., & Ma, Y. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.711564 · Cited by 184 · see citing works
ADAR Gene Family and A-to-I RNA Editing: Diverse Roles in Posttranscriptional Gene Regulation
Valente, L., & Nishikura, K. (2005) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)79006-6 · Cited by 168 · see citing works
RNA editing of the 5-HT2C receptor is reduced in schizophrenia
Sodhi, M., Burnet, P. W. J., MAKOFF, A. J., Kerwin, R., & Harrison, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000920 · Cited by 168 · see citing works
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
Hideyama, T., Yamashita, T., Suzuki, T., Tsuji, S., Higuchi, M., Seeburg, P. H., Takahashi, R., Misawa, H., & Kwak, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2021-10.2010 · Cited by 158 · see citing works
Porter, R. H. P., Eastwood, S. L., & Harrison, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01404-7 · Cited by 158 · see citing works
Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor
Fitzgerald, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00004-4 · Cited by 153 · see citing works
RNA editing in the forefront of epitranscriptomics and human health
Christofi, T., & Zaravinos, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2071-4 · Cited by 139 · see citing works
Lees, G. J. (2000) · Drugs · doi:10.2165/00003495-200059010-00004 · Cited by 138 · see citing works
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
Shehadeh, L. A., Yu, K. M., Wang, L., Guevara, A., Singer, C., Vance, J. M., & Papapetropoulos, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009104 · Cited by 132 · see citing works
Nucleic acid aptamers targeting cell-surface proteins
Dua, P., Kim, S., & Lee, D.-K. (2011) · Methods · doi:10.1016/j.ymeth.2011.02.002 · Cited by 122 · see citing works
Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease
Gaisler‐Salomon, I., Kravitz, E., Feiler, Y., Safran, M., Biegon, A. R., Amariglio, N., & Rechavi, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.018 · Cited by 119 · see citing works
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, N., Kimura, T., Yahara, O., & Kwak, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0678-x · Cited by 117 · see citing works
Adenosine Deaminases Acting on RNA, RNA Editing, and Interferon Action
George, C. X., Gan, Z., Liu, Y., & Samuel, C. E. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0097 · Cited by 117 · see citing works
Beneyto, M., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20329 · Cited by 113 · see citing works
ADAR1 and its implications in cancer development and treatment
Baker, A. R., & Slack, F. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.03.013 · Cited by 111 · see citing works
Structure and Sequence Determinants Required for the RNA Editing of ADAR2 Substrates
Dawson, T. R., Sansam, C. L., & Emeson, R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310068200 · Cited by 108 · see citing works
Toth, A. M., Zhang, P., Das, S., George, C. X., & Samuel, C. E. (2006) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(06)81010-x · Cited by 101 · see citing works
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00195-7 · Cited by 101 · see citing works
Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents
Ashe, P. C., Berry, M. D., & Boulton, A. A. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00159-2 · Cited by 100 · see citing works
Kortenbruck, G., Berger, E., Speckmann, E. ‐., & Mußhoff, U. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0394 · Cited by 97 · see citing works
Barbon, A., Popoli, M., Via, L. L., Moraschi, S., Vallini, I., Tardito, D., Tiraboschi, E., Musazzi, L., Giambelli, R., Gennarelli, M., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.018 · Cited by 93 · see citing works
Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders
Silberberg, G., Lundin, D., Navon, R., & Öhman, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr461 · Cited by 93 · see citing works
Glutamate in schizophrenia: clinical and research implications
GOFF, D. C., & Wine, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00079-0 · Cited by 93 · see citing works
Athanasiadis, A., Plácido, D., Maas, S., Brown, B. A., Lowenhaupt, K., & Rich, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.028 · Cited by 86 · see citing works
Aberrant RNA processing events in neurological disorders
Anthony, K., & Gallo, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.008 · Cited by 80 · see citing works
AMPA receptor-mediated neuronal death in sporadic ALS
Kwak, S., Hideyama, T., Yamashita, T., & Aizawa, H. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01090.x · Cited by 80 · see citing works
Defects in Pre-mRNA Processing as Causes of and Predisposition to Diseases
Stoilov, P., Meshorer, E., Gencheva, M., Glick, D., Soreq, H., & Stamm, S. (2002) · DNA and Cell Biology · doi:10.1089/104454902320908450 · Cited by 80 · see citing works
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia
Tucholski, J., Simmons, M. S., Pinner, A. L., Haroutunian, V. H., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.031 · Cited by 77 · see citing works
Characterization of the AMPA‐Activated Receptors Present on Motoneurons
Greig, A., Donevan, S. D., Mujtaba, T., Parks, T. N., & Rao, M. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740179.x · Cited by 77 · see citing works
Genome-wide analysis of differential RNA editing in epilepsyPreprint
Srivastava, P. K., Bagnati, M., Delahaye‐Duriez, A., Ko, J., Rotival, M., Langley, S. R., Shkura, K., Mazzuferi, M., Danis, B., van Eyll, J. M., et al. (2017) · Genome Research · doi:10.1101/gr.210740.116 · Cited by 77 · see citing works
Kawahara, Y., Ito, K., Sun, H., Kanazawa, I., & Kwak, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02718.x · Cited by 73 · see citing works
Synaptic Dysfunction in Huntington’s Disease: Lessons from Genetic Animal Models
Cepeda, C., & Levine, M. S. (2020) · The Neuroscientist · doi:10.1177/1073858420972662 · Cited by 68 · see citing works
RNA rewriting, recoding, and rewiring in human disease
Zipeto, M., Jiang, Q., Melese, E. S., & Jamieson, C. H. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.07.001 · Cited by 70 · see citing works
Konen, L. M., Wright, A. L., Royle, G. A., Morris, G. P., Lau, B. K., Seow, P. W., Zinn, R., Milham, L. T., Vaughan, C. W., & Vissel, B. (2020) · Molecular Brain · doi:10.1186/s13041-020-0545-1 · Cited by 72 · see citing works
Ying, H. S.-C., Weishaupt, J. H., Grabb, M. C., Canzoniero, L. M. T., Sensi, S. L., Sheline, C. T., Monyer, H., & Choi, D. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09536.1997 · Cited by 66 · see citing works
Potashkin, J., & Meredith, G. E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.144 · Cited by 65 · see citing works
Novel RNA Modifications in the Nervous System: Form and Function
Satterlee, J. S., Basanta‐Sanchez, M., Blanco, S., Li, J. B., Meyer, K. D., Pollock, J. D., Sadri‐Vakili, G., & Rybak‐Wolf, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3236-14.2014 · Cited by 63 · see citing works
Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli, M. A., Chabot, J.-G., Williams, S., Mechawar, N., Quirion, R., & Krantic, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00327 · Cited by 63 · see citing works
RNA metabolism in ALS: When normal processes become pathological
Droppelmann, C. A., Campos‐Melo, D., Ishtiaq, M., Volkening, K., & Strong, M. J. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.881377 · Cited by 61 · see citing works
Favero, G., Campanella, L., Cavallo, S., D’Annibale, A., Perrella, M., Mattei, E., & Ferri, T. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042904g · Cited by 63 · see citing works
Ravindranathan, A., Donevan, S. D., Sugden, S. G., Greig, A., Rao, M. S., & Parks, T. N. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00667.x · Cited by 63 · see citing works
Tomiyama, M., Rodríguez‐Puertas, R., Cortés, R., Christnacher, A., Sommer, B., Pazos, Á., Palacios, J. M., & Mengod, G. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00321-1 · Cited by 62 · see citing works
A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia
Kubota‐Sakashita, M., Iwamoto, K., Bundo, M., & Kato, T. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-5 · Cited by 60 · see citing works
RNA dysregulation in neurodegenerative diseases
Li, Y., & Sun, S. (2025) · The EMBO Journal · doi:10.1038/s44318-024-00352-6 · Cited by 62 · see citing works
Human retinohypothalamic tract as revealed by in vitro postmortem tracing
Dai, J., van der Vliet, J., Swaab, D. F., & Buijs, R. M. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980803)397:3 · Cited by 83 · see citing works
Self-citationExcitotoxicity and ALS: What is unique about the AMPA receptors expressed on spinal motor neurons?
Kawahara, Y., & Kwak, S. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510037872 · Cited by 58 · see citing works
Structure of Ionotropic Glutamate Receptors
Hollmann, M. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08022-1_1 · Cited by 55 · see citing works
Glutamate receptor RNA editing in health and disease
Barbon, A., & Barlati, S. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911080037 · Cited by 58 · see citing works
Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
Lauterbach, E. C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122558 · Cited by 51 · see citing works
Laslo, P., Lipski, J., Nicholson, L. F. B., Miles, G. B., & Funk, G. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7653 · Cited by 53 · see citing works
Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama, T., & Kawahara, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03466-2 · Cited by 51 · see citing works
Expanding genome capacity via RNA editing
Gott, J. M. (2003) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2003.09.004 · Cited by 52 · see citing works
Tomiyama, M., Palacios, J. M., Cortés, R., Vilaró, M. T., & Mengod, G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00022-3 · Cited by 50 · see citing works
RNA-binding proteins as molecular links between cancer and neurodegeneration
Campos‐Melo, D., Droppelmann, C. A., Volkening, K., & Strong, M. J. (2014) · Biogerontology · doi:10.1007/s10522-014-9531-2 · Cited by 49 · see citing works
Zhu, H., Urban, D. J., Blashka, J., McPheeters, M. T., Kroeze, W. K., Mieczkowski, P. A., Overholser, J. C., Jurjus, G., Dieter, L., Mahajan, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043227 · Cited by 47 · see citing works
Human Bcl‐2 Protects Against AMPA Receptor‐Mediated Apoptosis
Cheung, N. S., Beart, P. M., Pascoe, C. J., John, C. A., & Bernard, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741613.x · Cited by 47 · see citing works
Wright, A. L., Konen, L. M., Mockett, B. G., Morris, G. P., Singh, A., Burbano, L. E., Milham, L. T., Hoang, M., Zinn, R., Chesworth, R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00632-5 · Cited by 45 · see citing works
Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration
Singh, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00326 · Cited by 44 · see citing works
Epitranscriptomic dynamics in brain development and disease
Shafik, A. M., Allen, E. G., & Jin, P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01570-2 · Cited by 41 · see citing works
When Does ALS Start? ADAR2?GluA2 Hypothesis for the Etiology of Sporadic ALS
Hideyama, T., & Kwak, S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00033 · Cited by 43 · see citing works
Gruszczynska‐Biegala, J., Sladowska, M., & Kuźnicki, J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00251 · Cited by 42 · see citing works
Lohr, J. B., Alder, M., Flynn, K., Harris, M. J., & McAdams, L. A. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00006 · Cited by 41 · see citing works
Sodhi, M., Airey, D. C., Lambert, W. E., Burnet, P. W. J., Harrison, P. J., & Sanders‐Bush, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014134 · Cited by 39 · see citing works
Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
Pietraszek, M. (2003) · PubMed · Cited by 39 · see citing works
A method to find tissue-specific novel sites of selective adenosine deamination
Ohlson, J. I. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni169 · Cited by 39 · see citing works
RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains
Carlson, N. G., Howard, J., Gahring, L. C., & Rogers, S. W. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00127-5 · Cited by 37 · see citing works
Henderson, D. C., & Ettinger, E. R. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51014-x · Cited by 36 · see citing works
The Good and the Bad of Glutamate Receptor RNA Editing
Filippini, A., Bonini, D., Via, L. L., & Barbon, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0201-z · Cited by 33 · see citing works
RNA Editing and Retrotransposons in Neurology
Krestel, H. E., & Meier, J. C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00163 · Cited by 30 · see citing works
Dawn of Epitranscriptomic Medicine
Gatsiou, A., & Stellos, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001927 · Cited by 31 · see citing works
Fritschy, J., Weinmann, O., Wenzel, A., & Benke, D. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980112)390:2 · Cited by 321 · see citing works
Self-citationStine, C. D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00212-8 · Cited by 29 · see citing works
Interferons: potential roles in affect
E.C.Hurlock, I. V. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1218 · Cited by 29 · see citing works
Rocher, A. B., Gubellini, P., Mérienne, N., Boussicault, L., Petit, F., Gipchtein, P., Jan, C., Hantraye, P., Brouillet, E., & Bonvento, G. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.016 · Cited by 28 · see citing works
Lee, J. C., Greig, A., Ravindranathan, A., Parks, T. N., & Rao, M. S. R. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(98)00035-x · Cited by 28 · see citing works
Mizukami, K., Ishikawa, M., Iwakiri, M., Ikonomovic, M. D., DeKosky, S. T., Kamma, H., & Asada, T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.070 · Cited by 27 · see citing works
RNA Editing in Neurological and Neurodegenerative Disorders
Cruz, P. H. C., & Kawahara, Y. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0787-9_18 · Cited by 27 · see citing works
Activity Dependent Inhibition of AMPA Receptors by Zn 2+
Carrillo, E. C., Bhatia, N. K., Akimzhanov, A. M., & Jayaraman, V. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1481-20.2020 · Cited by 26 · see citing works
ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
Hajji, K., Sedmík, J., Cherian, A., Amoruso, D., Keegan, L. P., & O’Connell, M. A. (2022) · RNA · doi:10.1261/rna.079266.122 · Cited by 26 · see citing works
Hosaka, T., Tsuji, H., & Kwak, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010958 · Cited by 26 · see citing works
Lismer, A., Shao, X., Dumargne, M.-C., Lafleur, C., Lambrot, R., Chan, D., Toft, G. V., Bonde, J. P., MacFarlane, A. J., Bornman, R., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp12013 · Cited by 24 · see citing works
Inosine and its methyl derivatives: Occurrence, biogenesis, and function in RNA
Dutta, N., Deb, I., Sarzyńska, J., & Lahiri, A. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.01.001 · Cited by 23 · see citing works
- Authors
- Akbarian, S., Smith, M. A., & Jones, E. G.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Jones, Edward G.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1995-11
- Volume
- 699
- Issue
- 2
- Pages
- 297-304
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2073364812
- Cited by
- 183
- References
- 61
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 8 · 2012: 3
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50mh044188-05)
- U.S. Public Health Service
- University of California, Irvine
- National Institute of Mental Health (MH44188)
- National Institute on Drug Abuse
- National Institute of Neurological Disorders and Stroke (R01NS033213, NS-33213, NS21377, R01NS021377)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- AMPA receptors, prefrontal cortex, striatum, Alzheimer's disease, Huntington's disease, schizophrenia, calcium permeability, neuronal dysfunction, neurodegeneration
- MeSH terms
- Aged, Alzheimer Disease, Autoradiography, Corpus Striatum, Humans, Huntington Disease, Middle Aged, Nerve Degeneration, RNA, Schizophrenia, Prefrontal Cortex, Receptors, AMPA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review